Peter Beck's Rocket Lab Fell 30% in a Month While Revenue Grew 63%

Rocket Lab shares fell over the past month (down >30% at the worst point, still about -13% after a rebound) despite strong Q1 results. Revenue rose 63% YoY to a record $200M, but free cash flow was negative at $77M—wider than analysts expected—driving investor focus on cash burn. The company also narrowed its adjusted operating loss versus guidance and completed its Mynaric acquisition, expanding operations in Europe.

Analysis

The market is treating RKLB as a financing/balance-sheet story first and a growth story second. That usually persists until the company proves operating leverage is real, because vertical integration can improve control and margins only after a period of heavier capex, inventory, and integration drag. In other words, the next rerate is less about headline revenue and more about whether incremental growth stops consuming disproportionate cash.

Second-order, the moat argument cuts both ways: bringing more of the stack in-house can squeeze outside suppliers and reduce dependency risk, but it also increases execution complexity and raises the odds of lumpy margins. The European acquisition adds optionality on customer reach, yet near term it is a distraction risk if integration costs rise faster than cross-sell benefits. That makes this a stock where the path matters more than the destination.

Over the next 1-3 months, the stock should trade on cash burn trajectory, not top-line momentum. If burn narrows and management avoids signaling dilution, the setup can work for a sharp relief rerate; if burn stays elevated, the multiple likely compresses again even if revenue stays strong. The falsifier is simple: another quarter with materially negative free cash flow and no credible bridge to self-funding would turn this back into a capital-raise candidate, which would cap upside for 6-18 months.

Key Decisions for Investors

• Initiate only a starter long RKLB on weakness, not at current levels; use a 6-12 month horizon and require evidence that quarterly free-cash-flow burn is trending materially lower before adding. Falsifier: another quarter near or above the current burn rate, or any dilution/financing language.
• Prefer RKLB call spreads over common stock for upside exposure. The structure expresses a rerating if execution improves while limiting downside if the market continues to price in funding risk.
• If you want cleaner beta-neutral exposure, pair long RKLB vs short XAR (or UFO if liquidity is sufficient) after an earnings-driven drawdown. This isolates company execution from broad space-sector sentiment.
• Do not short the weakness blindly; only fade rallies if the next update shows no improvement in cash burn or integration costs. If that happens, a put spread becomes the cleaner expression of financing risk.
• Set an alert around the next quarterly print: if revenue growth stays robust but FCF burn fails to compress, expect another leg of multiple compression; if burn narrows and guidance implies no equity raise for 12 months, the stock can re-rate quickly.